NCT01501656View on ClinicalTrials.gov

Epigenetic Testing for Breast Cancer Risk Stratification

CompletedOBSERVATIONAL
Enrollment

158

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Breast Cancer
Trial Locations (1)

75204

UT Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of Texas Southwestern Medical Center

OTHER

NCT01501656 - Epigenetic Testing for Breast Cancer Risk Stratification | Biotech Hunter | Biotech Hunter